GO:0008146 sulfotransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008146 sulfotransferase activity is a molecular function that transfers a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a hydroxyl group on an acceptor substrate, producing a sulfated derivative and 3'-phosphoadenosine 5'-phosphate (PAP).
• Sulfotransferases regulate the biological activity of hormones, neurotransmitters, drugs, and xenobiotics by adding sulfate groups that alter their function and clearance.
• Dysregulated sulfotransferase activity is linked to human diseases including liver disease, breast cancer, and Alzheimer's disease-like neuroinflammation.
• Key sulfotransferase genes include SULT1A1, SULT1E1, SULT2A1, CHST family members, and NDST1, each with distinct substrate specificities and tissue distributions.
• Sulfotransferase activity can be studied using biochemical assays, CRISPR knockout models, and omics approaches to dissect substrate specificity and disease relevance.
• Targeting sulfotransferase activity is a promising therapeutic strategy in oncology and metabolic disorders, with several inhibitors and prodrug strategies under investigation.
Description
Sulfotransferase activity (GO:0008146) is a fundamental molecular function that catalyzes the transfer of a sulfate group from the universal sulfate donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the hydroxyl group of an acceptor molecule, yielding a sulfated product and 3'-phosphoadenosine 5'-phosphate (PAP). This enzymatic activity is essential for the metabolism of endogenous compounds such as steroids, neurotransmitters, and bile acids, as well as for the detoxification of xenobiotics and drugs. By altering the physicochemical properties of substrates, sulfation modulates their biological activity, receptor binding, and excretion. Researchers study sulfotransferase activity to understand hormone regulation, drug metabolism, and the pathogenesis of diseases ranging from cancer to neurodegeneration. The reaction is conserved across species and is carried out by a large superfamily of cytosolic and membrane-bound enzymes, each with distinct substrate preferences and tissue expression patterns. In this article, we provide a comprehensive overview of the mechanism, key genes, disease associations, and research methods for investigating sulfotransferase activity.
sulfotransferase activity At A Glance
| GO ID | GO:0008146 |
|---|---|
| GO term | sulfotransferase activity |
| Ontology | molecular_function |
| Synonym | sulphotransferase activity |
| Definition | Catalysis of the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate to the hydroxyl group of an acceptor, producing the sulfated derivative and 3'-phosphoadenosine 5'-phosphate. |
| Major function | Sulfation of hormones, neurotransmitters, drugs, and macromolecules, modulating their activity and clearance. |
| Cofactor | 3'-Phosphoadenosine 5'-phosphosulfate (PAPS) serves as the sulfate donor. |
| Subcellular location | Cytosol (SULTs) and Golgi membrane (CHST, NDST, HS6ST). |
| Representative genes | SULT1A1, SULT1E1, SULT2A1, CHST1, CHST3, NDST1, HS6ST1. |
What Is GO:0008146?
Sulfotransferase activity (GO:0008146) is defined as the catalysis of the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the hydroxyl group of an acceptor, producing the sulfated derivative and 3'-phosphoadenosine 5'-phosphate (PAP). This activity is also known as sulphotransferase activity. It is a molecular function classified under the ontology aspect molecular_function. The reaction typically involves the nucleophilic attack of a hydroxyl group on the sulfur atom of PAPS, leading to the formation of a sulfate ester or sulfamate bond. Sulfotransferases are classified into two major groups: cytosolic sulfotransferases (SULTs) that act on small molecules, and membrane-bound sulfotransferases (e.g., CHST, NDST, HS6ST) that modify macromolecules such as glycosaminoglycans and proteins.
Why Is sulfotransferase activity Important in Cell Biology?
Sulfotransferase activity is critically important because it regulates the bioavailability and function of numerous signaling molecules, including estrogens, androgens, thyroid hormones, and catecholamines, thereby influencing endocrine homeostasis and neuronal signaling. In drug metabolism, sulfation often inactivates drugs and facilitates their excretion, but it can also bioactivate prodrugs or generate reactive metabolites. Dysregulation of sulfotransferase activity has been implicated in the progression of hormone-dependent cancers, such as breast cancer, where altered sulfation affects estrogen receptor signaling. Moreover, sulfatide deficiency, a consequence of impaired sulfotransferase activity, has been shown to cause Alzheimer's disease-like neuroinflammation and cognitive impairment in mouse models. In liver disease, downregulation of sulfotransferase expression and activity impairs xenobiotic detoxification and bile acid homeostasis. Thus, understanding sulfotransferase activity is essential for drug development, endocrine research, and disease mechanism studies.
• Regulates the activity of steroid hormones, including estrogens and androgens, by sulfation.
• Modulates neurotransmitter signaling and is involved in neuronal development and function.
• Plays a key role in phase II drug metabolism, affecting drug efficacy and toxicity.
• Altered sulfotransferase activity is associated with breast cancer progression and prognosis.
• Sulfatide deficiency due to impaired sulfotransferase activity causes neuroinflammation and cognitive decline.
• Downregulation of sulfotransferases in diseased livers impairs detoxification and bile acid metabolism.
• Sulfotransferases are involved in the biosynthesis of glycosaminoglycans, affecting cell signaling and matrix structure.
• Genetic polymorphisms in SULT genes influence individual susceptibility to diseases and drug responses.
• Sulfotransferase activity can be targeted for therapeutic intervention in cancer and metabolic disorders.
• Sulfotransferases are used as biocatalysts for regioselective sulfation in synthetic chemistry.
What Happens During sulfotransferase activity?
Substrate Binding and PAPS Utilization
In simple terms: The enzyme grabs a sulfate group from PAPS and holds the target molecule ready for modification.
Sulfotransferases bind the universal sulfate donor PAPS and the acceptor substrate in a sequential or random order. The enzyme active site contains conserved residues that coordinate PAPS and position the hydroxyl group of the substrate for nucleophilic attack. For cytosolic SULTs, substrate binding often induces conformational changes that stabilize the transition state. Membrane-bound sulfotransferases, such as NDST1, utilize PAPS within the Golgi lumen to modify heparan sulfate chains.
Catalytic Transfer of Sulfate
In simple terms: The enzyme transfers the sulfate group from PAPS onto the target molecule, creating a sulfated product.
The catalytic mechanism involves the nucleophilic attack of the substrate hydroxyl group on the sulfur atom of PAPS, leading to the formation of a sulfate ester or sulfamate bond and the release of PAP. This reaction is often facilitated by a catalytic base that deprotonates the hydroxyl group, increasing its nucleophilicity. The sulfated product can have altered charge, solubility, and biological activity compared to the parent compound.
Product Release and PAP Turnover
In simple terms: After the reaction, the sulfated product and PAP leave the enzyme, and PAP is recycled.
Following catalysis, the sulfated product and PAP are released from the active site. PAP is a potent inhibitor of sulfotransferases and is rapidly degraded by 3'-nucleotidase to maintain enzyme activity. In cells, PAPS is regenerated from PAP via the PAPS synthase pathway, ensuring a continuous supply for sulfation reactions.
Regulation of Sulfotransferase Activity
In simple terms: The cell controls how much sulfation happens by adjusting enzyme levels and PAPS availability.
Sulfotransferase activity is regulated at multiple levels, including transcriptional control by nuclear receptors, post-translational modifications, and availability of PAPS. For example, in breast cancer, estrogen receptor signaling can influence SULT expression, affecting local estrogen levels. In the liver, inflammatory cytokines downregulate SULT expression, contributing to impaired drug metabolism.
Key Genes Involved in GO:0008146 sulfotransferase activity
The following genes encode sulfotransferases or related proteins that catalyze sulfate transfer and are widely studied in human biology and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SULT1A1 | Cytosolic sulfotransferase that sulfates phenols, estrogens, and drugs | Drug metabolism, cancer risk, and hormone regulation |
| SULT1E1 | Estrogen sulfotransferase that inactivates estradiol | Breast cancer and endocrine disorders |
| SULT2A1 | Sulfates bile acids, steroids, and xenobiotics | Liver disease and drug metabolism |
| SULT1B1 | Sulfates thyroid hormones and xenobiotics | Thyroid hormone homeostasis and detoxification |
| SULT1C2 | Sulfates various endogenous and exogenous compounds | Drug metabolism and carcinogen activation |
| SULT4A1 | Brain-specific sulfotransferase | Neurotransmitter regulation and neurodegeneration |
| CHST1 | Golgi sulfotransferase that modifies keratan sulfate | Glycosaminoglycan biosynthesis and cell signaling |
| CHST3 | Sulfates chondroitin sulfate | Skeletal development and connective tissue disorders |
| CHST11 | Chondroitin 4-sulfotransferase | Cartilage formation and cancer progression |
| NDST1 | N-deacetylase/N-sulfotransferase that modifies heparan sulfate | Heparan sulfate biosynthesis and signaling |
| NDST2 | N-deacetylase/N-sulfotransferase involved in mast cell heparin synthesis | Allergy and inflammation |
| HS6ST1 | Heparan sulfate 6-O-sulfotransferase | Growth factor signaling and development |
| HS3ST1 | Heparan sulfate 3-O-sulfotransferase | Anticoagulation and viral entry |
| UST | Uronyl 2-sulfotransferase | Dermatan sulfate biosynthesis |
| TPST1 | Tyrosylprotein sulfotransferase 1 | Protein sulfation and chemokine signaling |
| TPST2 | Tyrosylprotein sulfotransferase 2 | Protein sulfation and immune regulation |
| PAPSS1 | PAPS synthase 1, synthesizes the sulfate donor PAPS | Sulfation capacity and drug metabolism |
| PAPSS2 | PAPS synthase 2, synthesizes PAPS in Golgi | Cartilage development and sulfation disorders |
How Is sulfotransferase activity Regulated?
Sulfotransferase activity is regulated at transcriptional, post-transcriptional, and post-translational levels. Nuclear receptors such as PXR, CAR, and ERα modulate the expression of SULT genes in response to xenobiotics and hormones. Inflammatory cytokines, including IL-6 and TNF-α, downregulate hepatic SULT expression during acute phase response, leading to reduced drug sulfation. The availability of the cofactor PAPS, controlled by PAPSS1 and PAPSS2, also limits sulfation capacity. Additionally, PAP, the product of the reaction, acts as a competitive inhibitor, and its rapid degradation by 3'-nucleotidase is essential for maintaining enzyme activity. Post-translational modifications, such as phosphorylation, can affect SULT stability and subcellular localization.
sulfotransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SULT1E1 | Breast cancer (estrogen-dependent) | Knockout of SULT1E1 in MCF-7 cells to assess estrogen signaling |
| SULT2A1 | Liver disease (cholestasis) | Hepatocyte-specific SULT2A1 knockout mice |
| CST (CHST3) | Alzheimer's disease-like neuroinflammation | Inducible knockout of CST in oligodendrocytes |
| SULT1A1 | Drug metabolism (minoxidil response) | Point mutation of SULT1A1 in keratinocytes to test minoxidil sulfation |
| NDST1 | Heparan sulfate-related developmental disorders | NDST1 knockout in zebrafish or mouse models |
Sulfotransferase Activity in Liver Disease
Downregulation of sulfotransferase expression and activity has been observed in diseased human livers, including those with cirrhosis and hepatocellular carcinoma. This reduction impairs the sulfation of drugs and endogenous compounds, contributing to altered drug metabolism and accumulation of toxic bile acids. The decreased activity is partly due to inflammatory cytokine-mediated repression of SULT genes. Restoring sulfotransferase activity could improve hepatic detoxification and bile acid homeostasis in liver disease patients.
Sulfotransferase Activity and Breast Cancer
Sulfotransferases play a dual role in breast cancer: they can inactivate estrogens, reducing estrogen receptor signaling, but they can also sulfonate procarcinogens into reactive metabolites. SULT1E1, which sulfates estradiol, is often downregulated in breast tumors, leading to increased local estrogen levels and tumor growth. Conversely, SULT1A1 can activate dietary carcinogens, increasing cancer risk. Targeting sulfotransferase activity is being explored as a therapeutic strategy in hormone-dependent breast cancer.
Sulfatide Deficiency and Alzheimer's Disease
Sulfatide, a major myelin glycosphingolipid, is synthesized by sulfotransferases such as CST (cerebroside sulfotransferase). Adult-onset CNS myelin sulfatide deficiency in mice causes Alzheimer's disease-like neuroinflammation and cognitive impairment. This model demonstrates that loss of sulfotransferase activity in oligodendrocytes can trigger neuroinflammation and neurodegeneration, highlighting the importance of sulfation in brain health.
Sulfotransferase Activity in Drug Metabolism and Detoxification
Sulfotransferases are phase II drug-metabolizing enzymes that conjugate drugs and xenobiotics with sulfate, typically increasing their water solubility and facilitating excretion. For example, minoxidil, a hair growth drug, is sulfated by SULT1A1 to its active metabolite minoxidil sulfate. Altered sulfotransferase activity due to genetic polymorphisms or disease can affect drug efficacy and toxicity. Understanding these pathways is crucial for personalized medicine and drug development.
From sulfotransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SULT1E1 increase estrogen signaling in breast cancer? | CRISPR knockout of SULT1E1 in MCF-7 cells |
| Does SULT2A1 deficiency exacerbate liver injury? | Liver-specific SULT2A1 knockout mice |
| Does sulfatide deficiency cause cognitive impairment? | Inducible CST knockout in mouse oligodendrocytes |
| Does a SULT1A1 polymorphism affect minoxidil activation? | Point mutation knock-in of SULT1A1 variant in keratinocytes |
| Does NDST1 sulfation activity regulate heparan sulfate signaling? | NDST1 knockout in mouse embryonic fibroblasts |
| Can overexpression of SULT1A1 enhance drug detoxification? | SULT1A1 overexpression in HepG2 cells |
How to Study the sulfotransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive sulfotransferase assay | Enzyme activity using [35S]PAPS | Kinetic analysis of SULTs |
| CRISPR knockout | Loss-of-function effects | Gene function studies in cells and mice |
| CRISPR knock-in | Point mutation effects | Modeling human polymorphisms |
| RNA-seq | Gene expression levels | Tissue-specific SULT expression |
| Proteomics | Protein abundance and modifications | Sulfotransferase protein quantification |
| Metabolomics | Sulfated metabolite levels | Global sulfation capacity |
| Fluorescence microscopy | Subcellular localization | Golgi trafficking of CHSTs |
| HPLC/TLC | Separation of sulfated products | Product identification |
Biochemical Assays for Sulfotransferase Activity
Sulfotransferase activity is commonly measured using radioactive or fluorescent substrates and PAPS as the sulfate donor. For example, estradiol sulfotransferase activity can be assayed in cell lysates using [35S]PAPS and estradiol, followed by separation of sulfated products by thin-layer chromatography or HPLC. These assays allow determination of kinetic parameters and substrate specificity.
CRISPR-Cas9 Knockout and Knock-in Models
CRISPR-Cas9 genome editing enables the generation of knockout cell lines and animal models to study the loss of sulfotransferase function. For instance, knockout of NDST1 in mouse cells has been used to dissect its role in heparan sulfate N-sulfation. Knock-in of point mutations, such as SULT1A1 variants, can model human polymorphisms and their impact on drug metabolism.
Omics Approaches to Study Sulfation
Transcriptomics (RNA-seq) and proteomics can quantify sulfotransferase expression across tissues and disease states. For example, RNA-seq of diseased human livers revealed downregulation of multiple SULT genes. Metabolomics can identify sulfated metabolites and assess global sulfation capacity. These approaches provide systems-level insights into sulfotransferase regulation.
Imaging and Subcellular Localization
Fluorescent tagging of sulfotransferases, such as GFP fusion, allows visualization of their subcellular localization in live cells. Golgi-resident sulfotransferases like NDST1 can be imaged to study their trafficking and activity. Co-localization with Golgi markers confirms proper localization and function.
How CRISPR Can Be Used to Study GO:0008146 sulfotransferase activity
Knockout
CRISPR knockout of sulfotransferase genes, such as SULT1E1 or NDST1, enables the study of loss-of-function phenotypes in cell lines and animal models. For example, NDST1 knockout in mouse embryonic fibroblasts abolishes heparan sulfate N-sulfation, affecting growth factor signaling. Knockout models are essential for validating the role of specific sulfotransferases in drug metabolism and disease.
Point Mutation
CRISPR-mediated point mutations can mimic naturally occurring single-nucleotide polymorphisms (SNPs) in SULT genes, such as SULT1A1*2, which affects enzyme activity and drug response. These models help determine how specific amino acid changes alter substrate specificity or catalytic efficiency. Point mutation knock-in is particularly useful for pharmacogenomics studies.
Knock-in
Knock-in of tagged or reporter constructs, such as GFP-SULT1A1, allows real-time tracking of enzyme localization and dynamics. Knock-in of disease-associated mutations, like those in PAPSS2, can model sulfation disorders. These models provide insights into protein trafficking and function in a physiological context.
Overexpression
Overexpression of sulfotransferases, such as SULT1A1 or SULT2A1, in cell lines like HepG2 or HEK293, can enhance sulfation capacity and protect against xenobiotic toxicity. Overexpression models are used to study substrate specificity and to screen for inhibitors or activators. They also help assess the impact of elevated sulfation on hormone signaling.
How EDITGENE Supports sulfotransferase activity Research
Researchers studying sulfotransferase activity-related genes often need to determine whether a candidate gene is causally involved in sulfation pathways, drug metabolism, or disease progression. EDITGENE provides comprehensive CRISPR gene editing services to create precisely engineered cell models that enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for sulfotransferase activity research.
Frequently Asked Questions About sulfotransferase activity
What is sulfotransferase activity?
Sulfotransferase activity (GO:0008146) is the catalysis of the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the hydroxyl group of an acceptor, producing a sulfated derivative and 3'-phosphoadenosine 5'-phosphate (PAP).
What genes are involved in sulfotransferase activity?
Key genes include SULT1A1, SULT1E1, SULT2A1, SULT1B1, SULT4A1, CHST1, CHST3, NDST1, NDST2, HS6ST1, HS3ST1, TPST1, TPST2, PAPSS1, and PAPSS2.
What diseases are associated with sulfotransferase activity?
Dysregulated sulfotransferase activity is linked to liver disease, breast cancer, Alzheimer's disease-like neuroinflammation, and drug metabolism disorders.
How is sulfotransferase activity measured?
It is measured using biochemical assays with radioactive or fluorescent substrates and PAPS, often followed by HPLC or TLC separation of sulfated products.
What is the role of PAPS in sulfotransferase activity?
PAPS (3'-phosphoadenosine 5'-phosphosulfate) is the universal sulfate donor that provides the sulfate group transferred to acceptor substrates.
Can sulfotransferase activity be targeted for cancer therapy?
Yes, modulating sulfotransferase activity is being explored in breast cancer, where sulfation affects estrogen signaling and carcinogen activation.
What are the different types of sulfotransferases?
Sulfotransferases are classified into cytosolic SULTs (e.g., SULT1A1, SULT1E1) that act on small molecules, and membrane-bound sulfotransferases (e.g., CHST, NDST, HS6ST) that modify macromolecules like glycosaminoglycans.
How does sulfotransferase activity affect drug metabolism?
Sulfation typically inactivates drugs and increases their water solubility for excretion, but it can also bioactivate prodrugs like minoxidil.
What is the link between sulfotransferase activity and Alzheimer's disease?
Sulfatide deficiency due to impaired sulfotransferase activity in myelin causes Alzheimer's disease-like neuroinflammation and cognitive impairment in mice.
How can CRISPR be used to study sulfotransferase activity?
CRISPR knockout, knock-in, and overexpression models allow researchers to dissect the function of specific sulfotransferases in cells and animals, revealing their roles in metabolism and disease.
Conclusion
Sulfotransferase activity (GO:0008146) is a vital molecular function that regulates the biological activity of hormones, neurotransmitters, drugs, and macromolecules through sulfate conjugation. Its dysregulation contributes to liver disease, breast cancer, and neurodegeneration, making it a compelling target for therapeutic intervention. Advances in CRISPR gene editing and omics technologies are accelerating our understanding of sulfotransferase biology and its role in human health. Continued research into the mechanisms, regulation, and disease associations of sulfotransferase activity will pave the way for novel diagnostics and treatments.
References
- 1. Gupta AK et al.. 2022. Minoxidil: a comprehensive review.. J Dermatolog Treat 33(4):1896-1906 PMID: 34159872
- 3. Qiu S et al.. 2021. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.. Mol Neurodegener 16(1):64 PMID: 34526055
- 4. Yalcin EB et al.. 2013. Downregulation of sulfotransferase expression and activity in diseased human livers.. Drug Metab Dispos 41(9):1642-50 PMID: 23775849
- 5. Ramaswamy SG et al.. 1987. Amine N-sulfotransferase.. J Biol Chem 262(21):10039-43 PMID: 3475273
- 6. Ji XW et al.. 2015. Breast cancer treatment and sulfotransferase.. Expert Opin Ther Targets 19(6):821-34 PMID: 25677121
- 7. Dou W et al.. 2015. Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate.. J Biol Chem 290(33):20427-37 PMID: 26109066
- 8. Raeside JI et al.. 2000. Estradiol-17beta sulfotransferase activity in canine osteosarcoma D17 cells.. Biochem Biophys Res Commun 273(2):505-8 PMID: 10873635
